Cereno Scientific AB Logo

Cereno Scientific AB

Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.

CRNO | ST

Overview

Corporate Details

ISIN(s):
SE0008241541 (+3 more)
LEI:
549300VX8KTMYDS6NM84
Country:
Sweden
Address:
BioVentureHub, 431 83 Mölndal
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Cereno Scientific AB is a clinical-stage biotechnology company focused on developing innovative, disease-modifying treatments for rare cardiovascular and pulmonary diseases. The company's pipeline includes drug candidates in both clinical and preclinical phases. Its clinical portfolio utilizes epigenetic modulation through an HDACi (histone deacetylase inhibitor) platform. A key preclinical asset, CS585, is a novel prostacyclin (IP) receptor agonist. Cereno's strategy targets diseases with significant unmet medical needs, aiming to provide high treatment value to patients while leveraging a business model that allows for potentially shorter development timelines and accelerated market entry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cereno Scientific AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cereno Scientific AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cereno Scientific AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-16 Sten Sörensen Other Other 866,665 86,666.50 SEK
2024-11-25 Security Holding Sverige AB Other Buy 20,000 99,800.00 SEK

Peer Companies

Company Country Ticker View
INTAGE HOLDINGS Inc. Logo
Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.
Japan 4326
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France ALINT
Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan 7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan 9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea 287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea 216400
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden ISOFOL

Talk to a Data Expert

Have a question? We'll get back to you promptly.